Discover the power of predictive modeling to forecast future outcomes using regression, neural networks, and more for improved business strategies and risk management.
Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial. This is an ASCO Meeting Abstract from the 2025 ...
n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...
This study aims to improve survival modeling in head and neck cancer (HNC) by integrating patient-reported outcomes (PROs) using dimensionality reduction techniques. PROs capture symptom severity ...
When pitching the use of a model, data scientists rarely report on its potential value. They then experience an unnerving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results